Levetiracetam Solution
FDA Label NDC 0121-1598

96 label sections · Submitted to the FDA by Pai Holdings, Llc Dba Pai Pharma · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Pai Holdings, Llc Dba Pai Pharma for the product Levetiracetam (NDC 0121-1598). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding 1.1 partial-onset seizures, 1.2 myoclonic seizures in patients with juvenile myoclonic epilepsy, 1.3 primary generalized tonic-clonic seizures, 2.1 important administration instructions, 2.2 dosing for partial-onset seizures, adults 16 years of age and older, 1 month to < 6 months, 6 months to < 4 years, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Label Section Quick Index

* Please review the disclaimer below.